IL6 and leukemia: Inflammatory pathways mediated by interleukin (IL) 1b, IL-6, IL-1RAP, IL-8, and others lead to growth of aberrant leukemia and MDS stem and progenitors while inhibiting healthy hematopoiesis (27).